EHRA Premium Access

Primary prevention in systolic dysfunction/heart failure patients: use, misuse, and underuse

Congress Presentation

About the speaker

Associate Professor Markus Zabel

University Medical Centre of Gottingen (UMG), Goettingen (Germany)
4 presentations
0 follower

4 more presentations in this session

Antitachycardia pacing and VT termination: fact or fancy? What is the impact on shock reduction from a patient's perspective?

Speaker: Doctor U. Birgersdotter-Green (San Diego, US)

Thumbnail

No more therapy delivery after ventricular tachycardia ablation? Will my patient fear shock again?

Speaker: Doctor A. Berruezo Sanchez (Barcelona, ES)

Thumbnail

Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-MI patients with ejection fraction over 40% at SCD risk, insights from the PRESERVE EF study

Speaker: Doctor K. Trachanas (Athens, GR)

Thumbnail

Sudden death prevention and ICD therapy: unsolved issues - discussion

Thumbnail

Access the full session

Sudden death prevention and ICD therapy: unsolved issues

Speakers: Associate Professor M. Zabel, Doctor U. Birgersdotter-Green, Doctor A. Berruezo Sanchez, Doctor K. Trachanas
Thumbnail

About the event

Image

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb